Coagulant and procoagulant venom components

Coagulant and procoagulant venom components are a heterogeneous group of proteins found in the venom of various snakes, particularly within the Viperidae and Elapidae families, that accelerate the blood clotting cascade (Slagboom et al., 2017, Toxins). These components primarily include snake venom serine proteases (SVSPs) and snake venom metalloproteinases (SVMPs) that function as exogenous activators of prothrombin, Factor X, or Factor V, as well as thrombin-like enzymes that directly cleave fibrinogen (Kini, 2005, Journal of Thrombosis and Haemostasis). In the context of envenomation, these toxins lead to venom-induced consumption coagulopathy (VICC), a life-threatening state characterized by the depletion of clotting factors and subsequent risk of major hemorrhage (Maduwage & Isbister, 2014, PLoS Negl Trop Dis). Beyond their toxicological role, these molecules are significant in pharmacology; for example, batroxobin and ancrod have been utilized as therapeutic defibrinogenating agents to treat stroke and peripheral vascular disease (Sajevic et al., 2011, Toxicon). Management of toxicity involves the use of specific or polyvalent antivenoms, while research into small-molecule inhibitors like marimastat aims to provide adjunct treatments for snakebite (Slagboom et al., 2017, Toxins). These components are also essential diagnostic tools, with enzymes like ecarin used to monitor anticoagulation therapy (Kini, 2005, Journal of Thrombosis and Haemostasis).

Other names

Snake venom procoagulantsProcoagulant toxinsVenom-derived hemostatic factorsSnake venom serine proteasesSnake venom metalloproteinasesThrombin-like enzymes

Procoagulant venom components function by proteolytically activating key zymogens in the coagulation cascade, such as prothrombin and Factor X, or by acting as thrombin-like enzymes that directly cleave fibrinogen into fibrin (Kini, 2005, Journal of Thrombosis and Haemostasis; Slagboom et al., 2017, Toxins).